ADMA Biologics, Inc.

ADMANASDAQ • USD
13.95 USD
↗ 0.27 (1.94%)🟢LIVE (AS OF 11:15 AM EST)
🟢Market: OPEN

ADMA is currently priced at $13.95. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On valuation, ADMA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$13.72
High?$14.02
Low?$13.61
Prev. Close?$13.68
Volume?726.0K
Avg. Volume?3.7M
VWAP?$13.85
Rel. Volume?0.19x
Bid / Ask
Bid?$13.85 × 200
Ask?$13.86 × 300
Spread?$0.01
Midpoint?$13.86
Valuation & Ratios
Market Cap?3.0B
Shares Out?221.9M
Float?215.1M
Float %?96.0%
P/E Ratio?16.64
P/B Ratio?6.92
EPS?$0.82
Dividend?0.00%
Ex-Dividend?N/A
RelatedALLOACAD
News
Profile
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Employees
647
Market Cap
3.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2013-10-17
Address
C/O ADMA BIOLOGICS, INC.
RAMSEY, NJ 07446
Phone: (201) 478-5552
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
75
Short Sent.?
39
Piotroski F-Score?3/9Weak
Altman Z-Score?8.69Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.39%Elevated
Short Interest?18.0M
Days to Cover?7.1
Free Float215.1M
Avg Daily Volume2.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?6.04Strong
Quick Ratio?3.25Strong
Cash Ratio?1.31Strong
Debt/Equity?0.45Low
ValuationFAIRLY VALUEDvs 2 peers + S&P 500
Score
72/100
P/E?
Peers
50
S&P
76
16.6CHEAP▾
P/B?
Peers
33
S&P
27
6.92FAIR▾
P/S?
Peers
67
S&P
23
5.85FAIR▾
P/FCF?
Peers
100
S&P
46
22.8FAIR▾
EV/EBITDA?
Peers
100
S&P
63
12.9FAIR▾
EV/Sales?
Peers
67
S&P
28
5.98FAIR▾
Returns & Efficiency
ROE?
Peers
100
S&P
89
41.6%STRONG▾
ROA?
Peers
100
S&P
97
24.9%STRONG▾
Cash Flow & Enterprise
FCF?$132.9M
Enterprise Value?$3.1B
Fundamentals ratios updated end of day